Namzaric Capsule
Product Images NDC 0456-1221
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Namzaric (NDC 0456-1221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Namzaric 02
Namzaric 03
Namzaric 04
Namzaric 05
Namzaric 06
Namzaric 07
This text appears to be a table indicating clinical data for a drug called donepezil hydrochloride, administered at a dosage of 10mg/day. The table includes a score labeled "SIB Change from Baseline" and its mean value represented by -8, although it is unclear what this score represents. The table also mentions a time period of 36 months for drug treatment.*
Namzaric 08
The text contains some medication names and dosage (donepezil hydrochloride 10 mg/day) and a reference to placebo. There are also some symbols and characters that are not recognizable as words. The text seems to refer to some data related to a certain medical treatment, possibly related to a study or a clinical trial, but without further context, it is not possible to generate a more specific description.*
Namzaric 09
Namzaric 0a
Namzaric 0b
Namazaric is a medication available in the form of a capsule, in a bottle containing 30 capsules. The capsule is composed of two active ingredients, memantine HCI extended release (7 mg) and donepezil HCL (10 mg). The capsule should be taken once daily, according to the usual dosage, with instructions provided in the package insert for full Prescribing Information. The medication should be stored in a tightly-sealed, light-resistant container at 20°C to 25°C (68°F to 77°F) with allowable excursions between 15°C and 30°C (59°F and 86°F), as defined in the USP. Namazaric is RX only and distributed in the USA by Allergan, Inc. The medication should be kept out of reach of children.*
Namzaric 0c
Namzaric 0d
Namzaric® is a prescription medication available in the form of extended-release capsules. It contains a combination of memantine and donepezil hydrochlorides. Each capsule has 21mg of memantine HCI extended release and 10mg of donepezil HCI. The usual dosage is one capsule a day. The medication should be stored in a tight, light-resistant container at a temperature of 20-25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The drug should be kept out of reach of children. This medication is distributed by Alergan USA, and it is Rx only.*
Namzaric 0e
Each capsule of Namzaric contains a combination of memantine HCI and donepezil HCI. The capsule contains 28g of memantine HCI extended release and 10mg of donepezil HCI. The usual dosage is one capsule per day. The drug should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The drug is distributed by Allergan USA and was made in Ireland. Please refer to the package insert for full prescribing information.*
Namzaric 0f
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.